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Background: Thyroid carcinoma in young women is rapidly increasing, and cosmesis plays an important role in
thyroid operations. Various endoscopic thyroid surgery approaches have been performed, and their application has
recently been extended. We performed endoscopic thyroid surgeries via a breast approach since 1999. Herein, we
evaluate the safety of this approach and identify the outcomes for differentiated thyroid carcinoma.
Methods: A total of 452 consecutive patients with thyroid and parathyroid disease underwent endoscopic
thyroidectomy via a breast approach at Uijeongbu St. Mary’s Hospital between November 1999 and December
2012. The inclusion criteria for endoscopic thyroidectomy included a benign tumour less than 4 cm in diameter,
malignant thyroid nodules less than 2 cm, and no evidence of lymph node metastasis or local invasion. We
analysed the clinicopathologic data and surgical factors of this approach.
Results: The mean age of the patients was 38.4 ± 10.6 years (range 11-73 years). The mean tumour size was 2.12 ±
1.17 cm (range 0.1-4 cm). The final tumour pathologies included papillary carcinoma (n = 120), follicular carcinoma
(n = 8), nodular hyperplasia (n = 266), follicular adenoma (n = 43), and Hüthle cell adenoma (n = 4). The mean
postoperative hospital stay was 3.8 ± 1.3 days (range 1-17 days). Temporary and permanent hypoparathyroidism
requiring calcium and vitamin D supplementation developed in 32 (7.1%) and 4 (0.9%) patients, respectively.
Transient vocal cord paresis occurred in 20 (4.4%) patients.
Conclusions: For patients with benign and low-risk malignant thyroid disease, endoscopic thyroidectomy via a
breast approach is a safe, feasible, and minimally invasive surgical method with minimal complications.
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Conventional open thyroidectomy remains the treatment
of choice for benign and malignant thyroid nodules, but
the surgery requires a long incision line on the neck and
leaves a long scar on the lower anterior neck. This inci-
sion may lead to prominent scarring that can develop
into keloid or hypertrophic scars and lead to paraesthe-
sia or hypaesthesia [1].
With the development of laparoscopic and endoscopic
surgery, thyroid and parathyroid surgery has recently
been attempted using an endoscopic approach. Since
endoscopic parathyroidectomy and thyroidectomy were
first introduced by Gagner and Huscher et al. [2,3], vari-
ous endoscopic thyroid surgery approaches have been* Correspondence: drbreast@catholic.ac.kr
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unless otherwise stated.devised, including cervical, axillary, breast, and anterior
chest approaches.
Endoscopic thyroidectomy was initially performed in
patients with benign thyroid nodules. As surgical experi-
ence was accumulated, the application of endoscopic
thyroidectomy was extended to patients with early cases
of thyroid cancer.
We have previously reported on the feasibility of endo-
scopic thyroidectomy compared with conventional open
thyroidectomy [4]. Since 1999, we have operated on 452
patients using endoscopic thyroidectomy via a breast ap-
proach. The results of our 13-year experience are pre-
sented in this article. The purpose of this study was to
evaluate the safety and surgical outcomes of endoscopic
thyroidectomy and to analyse the clinicopathologic fea-
tures, types of operation, operation time, and complica-
tions of this surgical approach.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Operator and assistant positions during endoscopic
thyroidectomy via a breast approach.
Figure 2 Illustration of the trocar site in endoscopic
thyroidectomy via a breast approach.
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Patients
A total of 452 consecutive patients with thyroid and
parathyroid disease underwent endoscopic thyroidec-
tomy via a breast approach at Uijeongbu St. Mary’s
Hospital between November 1999 and December 2012.
All operations were performed by a single surgeon
(JSK). Written informed consent was obtained from the
patients and their families. This study was reviewed and
approved by the institutional review board at Uijeongbu
St. Mary’s Hospital (UC13RISI0156).
Preoperative diagnoses of thyroid nodules were made
by ultrasonography and ultrasonography-guided fine
needle aspiration cytology (FNAC). If FNAC identified
malignancy or atypical cells that were suspicious for ma-
lignancy, computed tomography was performed to iden-
tify the tumour location, invasion, and central lymph
node metastasis.
The indications for endoscopic thyroidectomy were as
follows: 1) benign tumour with the largest diameter less
than 4 cm in size (as estimated by preoperative ultrason-
ography); 2) malignant thyroid nodules less than 2 cm in
size; and 3) no evidence of lymph node metastasis or
local invasion. Patients who had undergone neck surgery
or irradiation were excluded. Additional exclusion cri-
teria were lateral lymph node metastases, extrathyroid
extension, invasion into adjacent organs, or suspicion of
distant metastasis on the preoperative imaging.
We performed prophylactic ipsilateral central lymph
node dissection for differentiated thyroid carcinoma. All
patients with differentiated thyroid carcinoma were
treated with levothyroxine to suppress thyroid-stimulating
hormone, and all patients were regularly followed by ultra-
sonography and thyroglobulin at 6-month intervals. Dif-
ferentiated thyroid carcinomas were described using
tumour-node-metastasis (TNM) staging on the basis of
the 7th edition of the recommendations of the American
Joint Committee on Cancer (AJCC).
Surgical technique
All patients were prepared for endoscopic thyroidectomy
under general anaesthesia. After the patient was placed
in a supine position, a pillow was placed beneath the
shoulder to extend the head and neck. The operator and
scope assistant stood on the right side of the patient, the
first assistant stood on the left side of the patient, and
the monitors were placed on both sides of the patient
(Figure 1). To facilitate dissection and reduce bleeding,
approximately 50 ml of saline solution (including 1 ml
epinephrine and 20 ml bupivacaine) was injected into
the subcutaneous layer of the anterior chest and the sub-
platysmal space in the neck. A 10-mm incision was
made on the upper edge of the areola on the right side,
a 5-mm incision was made on the upper edge of theareola on the left side, a 5-mm incision was made in the
right parasternal region, and a 3-mm incision was made
in the right axillary area (Figure 2). Initially, the flaps
were dissected bluntly with a glass rod bar. After the
blunt dissection, ports were inserted through each inci-
sion. Carbon dioxide gas was injected with a pressure of
6 mmHg. A 30-degree 5-mm rigid endoscope (Olympus,
Figure 4 Identifying the recurrent laryngeal nerve.
Table 1 Clinicopathologic characteristics of 452 patients
who underwent endoscopic thyroidectomy via a breast
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parasternal region. To create adequate working space, an
additional dissection was performed with endoscopic
shears and hooks (ENDOPATH Probe Plus II, Ethicon
Endo-Surgery, Inc., Guaynabo, Puerto Rico, USA) by elec-
trical cauterization. The working space was extended from
the anterior chest to the thyroid cartilage level and laterally
to the medial edge of each of the sternocleidomastoid mus-
cles. After the extension of the flap, a midline division
was made between the strap muscle from the thyroid car-
tilage to the sternal notch (Figure 3). Ultrasonic shears
(Harmonic ACE, Ethicon Endo-Surgery, Inc., Guaynabo,
Puerto Rico, USA) were then used to expose and dissect
the thyroid gland from the inferior pole. The inferior
thyroid vessel and the isthmus of the thyroid gland were
divided using ultrasonic shears. After a careful dissection
of the inferolateral aspects of the thyroid gland, the recur-
rent laryngeal nerve and the inferior parathyroid gland
were identified (Figure 4), and the inferior thyroidal artery
and the middle thyroidal vein were identified and divided.
The superior pole of the gland was dissected, and the super-
ior thyroid vessel was divided with ultrasonic shears. After
the recurrent laryngeal nerve was identified, the thyroid
gland was separated from the trachea and Berry’s ligament
was carefully divided. After being placed in an endo-bag
(Sejong Medical, Seoul, Korea), the specimen was pulled
out through the endoscope port site. A frozen section of
the specimen was examined intraoperatively for pathologic
confirmation. The cavity was cleaned with a saline solution
before a meticulous haemostasis was performed. The strap
muscles were approximated with an absorbable suture. A
100-cc Jackson-Pratt drainage tube was left in the operative
bed through the endoscope port site.
Results
The clinicopathologic characteristics of the 452 patients
who underwent endoscopic thyroidectomy are presentedFigure 3 Division of the strap muscle.in Table 1. The mean age of the patients was 38.4 ±
10.6 years (range 11-73 years). The mean tumour size
was 2.12 ± 1.17 cm (range 0.1-4 cm). Four hundred
thirty-seven (96.7%) patients were female, and 15 (3.3%)
patients were male. The final pathologies of the tumours
included papillary carcinoma (n = 120), follicular carcin-
oma (n = 8), nodular hyperplasia (n = 266), follicular ad-
enoma (n = 43), Hüthle cell adenoma (n = 4), parathyroid
adenoma (n = 3), Hashimoto’s thyroiditis (n = 1), diffuse
hyperplasia (n = 4), granulomatous thyroiditis (n = 2),
and hyaline fibrosis (n = 1). The mean postoperative hos-
pital stay was 3.8 ± 1.3 days (range 1-17 days).
The mean operation times by operation type were as fol-
lows: total thyroidectomy (n = 3), 156.6 ± 48.0 min; total
thyroidectomy with central lymph node dissection (n = 47),
171.6 ± 38.9 min; near-total thyroidectomy (n = 9), 120.0 ±approach
Characteristics Results (n = 452)
Age (years) 38.4 ± 10.6 (range 11-73)
Gender Female 437 (96.7%)
Male 15 (3.3%)
Size (cm) 2.12 ± 1.17 (range 0.1-4)
Pathology Papillary carcinoma 120 (26.5%)
Follicular carcinoma 8 (1.8%)
Nodular hyperplasia 266 (58.8%)
Follicular adenoma 43 (9.5%)
Hüthle cell adenoma 4 (0.2%)




3.8 ± 1.3 (range 1-17)
Table 3 Clinicopathologic characteristics of the patients
with differentiated thyroid carcinoma (n = 128)
Characteristics Number
Tumour size (cm) 1.05 ± 0.79




Capsule invasion 26 (21.3%)
Extrathyroidal extension 6 (4.7%)
Lymphatic invasion 22 (20.0%)
Multiplicity 22 (17.2%)
Central lymph node metastasis 76 (59.4%)
Retrieved central lymph nodes 6.15 ± 4.90 (range 1-26)
Metastatic central lymph nodes 3.53 ± 2.78 (range 1-16)
TNM stage I 106 (92.2%)
II 0
III 9 (7.8%)
Mean follow-up period (months) 54.0 ± 35.7 (range 6-160)
Kim et al. BMC Surgery 2014, 14:49 Page 4 of 6
http://www.biomedcentral.com/1471-2482/14/4940.9 min; near-total thyroidectomy with central lymph
node dissection (n = 27), 159.9 ± 45.5 min; subtotal thyroid-
ectomy (n = 29), 130.7 ± 50.2 min; subtotal thyroidectomy
with central lymph node dissection (n = 2), 170.3 ±
35.4 min; lobectomy (n = 306), 104.6 ± 35.1 min; and lobec-
tomy with central lymph node dissection (n = 25), 128.0 ±
35.2 min (Table 2).
The characteristics of the 128 patients who underwent
endoscopic thyroidectomy are summarized in Table 3.
The mean tumour size was 1.05 ± 0.79 cm. The tumours
were located in the right lobe, left lobe, isthmus, and bi-
lateral lobes in 43.8%, 40.6%, 5.5%, and 9.4% of the pa-
tients, respectively. Multifocal tumours were identified
in 17.2% of patients. Extrathyroidal extensions and lymph
node metastases were present in 6 (4.7%) and 76 (59.4%)
patients, respectively. A total of 109 (92.2%) patients had
stage I disease, and 9 (7.8%) patients had stage III disease.
The mean follow-up period was 54.0 ± 35.7 months (range
6-160).
Temporary and permanent hypoparathyroidism that
required calcium and vitamin D supplementation oc-
curred in 32 (7.1%) and 4 (0.9%) of the 452 patients, re-
spectively. Transient vocal cord paresis occurred in 20
(4.4%) patients. Postoperative uncontrolled bleeding oc-
curred in 2 cases and was successfully controlled by
endoscopic surgery. No complications, such as tracheal
injury, oesophageal perforation, or flap perforation, oc-
curred during the operations (Table 4). 1 case were con-
verted to a conventional open thyroidectomy because of
uncontrolled bleeding.
In 128 patients with differentiated thyroid carcinoma,
72 patients underwent total thyroidectomy or near-total
thyroidectomy. Postoperative thyroglobulin(Tg) levels
were available for 60 of the 72 patients. Mean postopera-
tive Tg level was 0.78 ng/ml. 47 of these patients (78.3%)
had T4-suppressed level of Tg < 1.0 ng/ml.
Discussion
In accordance with the increased utilization of ultrason-
ography, the worldwide incidence of thyroid nodulesTable 2 Extent of surgery and mean operation time (min)
Extent of surgery Number Mean operation
time (min)
Total thyroidectomy 3 (0.7%) 156.6 ± 48.0
Total thyroidectomy with CLND* 47 (10.4%) 171.6 ± 38.9
Near-total thyroidectomy 9 (2.0%) 120.0 ± 40.9
Near-total thyroidectomy with CLND 27 (6.0%) 159.9 ± 45.5
Subtotal thyroidectomy 29 (6.4%) 130.7 ± 50.2
Subtotal thyroidectomy with CLND 2 (0.4%) 170.3 ± 35.4
Thyroid lobectomy 306 (67.4%) 104.6 ± 35.1
Thyroid lobectomy with CLND 25 (5.8%) 128.0 ± 35.2
*, central lymph node dissection.and carcinoma has progressively increased in recent de-
cades [5]. Because the incidence of thyroid carcinoma in
young women is rapidly increasing, cosmesis plays an
important role in thyroid operations. In addition to im-
proving the cosmetic results, endoscopic thyroidectomy
can reduce the postoperative hospital stay and postoper-
ative pain. Thus, various endoscopic thyroid surgical ap-
proaches have been performed, including cervical [6],
anterior chest wall [7], axilla [8,9], axilla-breast [10,11],
and breast [12,13]. While endoscopic thyroid surgery
has advantages over other techniques, endoscopic thy-
roid surgery presents disadvantages for surgeons with
limited experience. These disadvantages include a longer
learning curve, longer operation time, and the potential
for more severe injuries compared to the conventional
procedure; however, these disadvantages can be over-
come by experienced surgeons.Table 4 Postoperative complications (n = 452)
Complications Number
Hypoparathyroidism Temporary 32 (7.1%)
Permanent 4 (0.9%)





Wound infection 3 (0.7%)
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breast approach since 1999. Compared with various
endoscopic thyroid surgery techniques, such as conven-
tional open thyroidectomy, the breast approach has the
advantage of presenting a good visual field. Because a
5-mm endoscope is inserted into the right parasternal
region, both thyroid lobes, the recurrent laryngeal
nerves, the upper and lower parathyroid glands, and the
thyroid vessels can be identified with a symmetrical
view. With respect to cosmesis, patient satisfaction is
high. The circumareolar wounds of the breast nipples
and the 3-mm working port wound heal extremely well
and are rarely visible after the procedure unless hyper-
trophic scars or keloids form.
When contraindications are absent, endoscopic thy-
roidectomy has recently been applied for benign thyroid
tumours. However, safety guidelines for endoscopic thy-
roidectomy for thyroid cancer have not been published.
Thyroid cancer was initially considered to be a contra-
indication for endoscopic thyroidectomy [14]. However,
because differentiated thyroid cancers exhibit good prog-
noses, endoscopic thyroidectomies for low-risk thyroid
cancer are increasingly being performed. With the ad-
vent of new surgical skills and the accumulation of a
surgeon’s experiences, the indications for endoscopic
thyroidectomy are being extended. Currently, the indica-
tions for endoscopic thyroidectomy are as follows: pa-
tients younger than 45 years old; well-differentiated
thyroid cancer of less than 2 cm in diameter; no definite
evidence of local invasion or central lymph node metas-
tasis; no adhesion or fixation of enlarged lymph nodes
around the neck compartment; and patients who are in-
terested in endoscopic thyroid surgery [15]. We also per-
formed endoscopic thyroidectomy for malignant thyroid
carcinoma with the above-mentioned indications.
In 90 out of the 128 patients who underwent endo-
scopic thyroidectomy for thyroid carcinoma, ipsilateral
or bilateral central lymph node dissections were per-
formed with no risk of complications. In our study, the
mean number of retrieved lymph nodes was 6.15 ± 4.90
in the central compartment. In patients with thyroid car-
cinoma, central lymph node dissection is feasible using
our surgical technique.
The rates of transient and permanent hypoparathyr-
oidism after conventional open thyroidectomy range
from 0.3% to 49% and 0% to 14.3%, respectively, and the
rate of unintentional recurrent laryngeal nerve injury
ranges from 0% to 5.7% [16-18].
The results of this study were similar. Transient and
permanent hypoparathyroidism were observed in 7.1%
and 0.9% of patients, respectively. Transient and perman-
ent recurrent laryngeal nerve injuries were observed in
4.4% and 0% of patients, respectively. Compared with con-
ventional open thyroidectomy, our surgical techniquedoes not differ with respect to the incidences of hypopara-
thyroidism and recurrent laryngeal nerve injury.
There were no life-threatening operative complications
after the endoscopic thyroidectomies. While there were
cases of immediate postoperative bleeding (2 cases) and
wound infection (3 cases), these complications were cor-
rected without difficulty. Tracheal injury, oesophageal
injury, flap injury, and subcutaneous emphysema were
not observed.
In this study, 2 out of 128 patients developed recur-
rent thyroid carcinoma after endoscopic thyroidectomy.
One patient underwent endoscopic total thyroidectomy
with central lymph node dissection. Tumour histology
revealed papillary carcinoma. The tumour size was 2.2 cm,
and extrathyroidal extension was not observed, but central
lymph node metastasis was observed. The patient was
treated with radioactive iodine therapy. After 28 months,
the follow-up imaging study revealed metastases to the
central and right lateral lymph nodes. FNAC was per-
formed in the right lateral lymph node, which supported
the diagnosis of papillary carcinoma. Therefore, we per-
formed a modified radical neck dissection. Another pa-
tient underwent endoscopic lobectomy in September
2000. Tumour histology revealed papillary microcarci-
noma. The tumour was 0.5 cm in size. The patient was
treated with levothyroxine for serum thyrotropin (TSH)
suppression. After 132 months, a newly developed lesion
was observed in the contralateral thyroid lobe. We per-
formed open completion thyroidectomy with central
lymph node dissection. To date, no mortality has been
reported in these patients. Thus, endoscopic thyroidec-
tomy for thyroid carcinoma is safe, especially in cases of
low-risk differentiated thyroid carcinoma.
Conclusions
Endoscopic thyroidectomy via a breast approach is a
safe, feasible, and minimally invasive surgical method for
benign and low-risk malignant thyroid disease. This ap-
proach provides good operative results and has a low
complication rate. For selected thyroid disease patients
who worry about neck scars, endoscopic thyroidectomy
via a breast approach is an effective surgical option.
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